Theseus Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2014 - 2018
Revenue	970	855	536	495.31	417.91	Upgrade
Revenue Growth (YoY)	13.45%	59.51%	8.21%	18.52%	64.81%	Upgrade
Cost of Revenue	130	118	56	41.84	39.15	Upgrade
Gross Profit	840	737	480	453.47	378.76	Upgrade
Selling, General & Admin	769	763	478	354.26	271.68	Upgrade
Research & Development	217	221	132	101.12	69.1	Upgrade
Operating Expenses	986	984	610	455.38	340.78	Upgrade
Operating Income	-146	-247	-130	-1.91	37.98	Upgrade
Interest Expense	-43	-9	-40	-38.12	-21.84	Upgrade
Interest & Investment Income	29	4	2	10.5	9.2	Upgrade
Currency Exchange Gain (Loss)	10	-6	-5	3	1	Upgrade
Other Non Operating Income (Expenses)	-	-2	1	0.88	0.23	Upgrade
EBT Excluding Unusual Items	-150	-260	-172	-25.65	26.57	Upgrade
Merger & Restructuring Charges	-17	-11	-6	-	-	Upgrade
Asset Writedown	-2	-43	-	-2	-	Upgrade
Other Unusual Items	-	-	-	-	-20.51	Upgrade
Pretax Income	-169	-314	-178	-27.65	6.06	Upgrade
Income Tax Expense	10	5	2	-3.27	-21.08	Upgrade
Earnings From Continuing Operations	-179	-319	-180	-24.37	27.14	Upgrade
Net Income	-179	-319	-180	-24.37	27.14	Upgrade
Net Income to Common	-179	-319	-180	-24.37	27.14	Upgrade
Net Income Growth	-	-	-	-	-3.13%	Upgrade
Shares Outstanding (Basic)	71	69	67	66	63	Upgrade
Shares Outstanding (Diluted)	71	69	67	66	69	Upgrade
Shares Change (YoY)	3.56%	1.96%	1.71%	-3.79%	6.05%	Upgrade
EPS (Basic)	-2.52	-4.66	-2.68	-0.37	0.43	Upgrade
EPS (Diluted)	-2.52	-4.66	-2.68	-0.37	0.40	Upgrade
EPS Growth	-	-	-	-	-6.98%	Upgrade
Free Cash Flow	26	-129	39	48.42	22.74	Upgrade
Free Cash Flow Per Share	0.37	-1.88	0.58	0.73	0.33	Upgrade
Gross Margin	86.60%	86.20%	89.55%	91.55%	90.63%	Upgrade
Operating Margin	-15.05%	-28.89%	-24.25%	-0.39%	9.09%	Upgrade
Profit Margin	-18.45%	-37.31%	-33.58%	-4.92%	6.49%	Upgrade
Free Cash Flow Margin	2.68%	-15.09%	7.28%	9.78%	5.44%	Upgrade
EBITDA	-110	-210	-114	10.19	46.27	Upgrade
EBITDA Margin	-11.34%	-24.56%	-21.27%	2.06%	11.07%	Upgrade
D&A For EBITDA	36	37	16	12.1	8.29	Upgrade
EBIT	-146	-247	-130	-1.91	37.98	Upgrade
EBIT Margin	-15.05%	-28.89%	-24.25%	-0.39%	9.09%	Upgrade
Revenue as Reported	970	855	536	495.31	417.91	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q